J.P. MORGAN HEALTHCARE CONFERENCE. Joe Woody Chief Executive Officer
|
|
- Leona Pierce
- 6 years ago
- Views:
Transcription
1 J.P. MORGAN HEALTHCARE CONFERENCE Joe Woody Chief Executive Officer 0
2 OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and webcast, including our outlook, expectations and planning assumptions, and any estimates, projections, and statements relating to our business plans, growth opportunity or objectives, constitute forward-looking statements and are based upon management s expectations and beliefs concerning future events impacting the Company. These statements are subject to risks and uncertainties, including currency exchange risks, cost savings and reductions, raw material, energy, and other input costs, competition, market demand, economic conditions, business and technology acquisitions, product development execution, S&IP separation execution and legislative and regulatory actions. There can be no assurance that these future events will occur as anticipated or that the Company s results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them. For a more complete listing and description of other factors that could cause the Company s future results to differ materially from those expressed in any forward-looking statements, see the Company s most recent Form 10-K and Quarterly Reports on Form 10-Q. NON-GAAP FINANCIAL MEASURES Management believes that non-gaap financial measures enhance investors understanding and analysis of the company s performance. As such, results and outlook have been adjusted to exclude certain items for relevant time periods as indicated in the non-gaap reconciliations to the comparable GAAP financial measures included in this presentation posted on our website ( 1
3 Focused Medical Devices company to deliver superior returns Pure-play Medical Devices company in attractive end markets Dual-track growth strategy focused on M&A and product development Scalable infrastructure and disciplined plan to right-size cost structure Invest in R&D capabilities and introduce innovative technology Allows for clear playbook for future double-digit revenue and earnings growth 2
4 Halyard s evolution to a focused Medical Devices company Formation of Halyard Became independent publicly-traded company Built infrastructure Developed R&D capability Attracted top-tier Board Increased Medical Devices growth Accelerated investment for organic growth Executed Corpak acquisition Generated record cash flow Continued to meet or surpass external expectations Appointed new leadership Medical Devices organic revenue growing mid-single digit Announced S&IP divestiture Underpinned by strong business momentum in Medical Devices ($ in millions) $ % 25.0% $600 $550 $500 $ % 20.8% 21.2% $600 $567 $502 $ A 2015A 2016A LTM 9/30/17A 23.0% 21.0% 19.0% Medical Devices Net Sales Operating Profit Margin 3
5 Multi-year transformation accelerated with S&IP sale Transaction Overview Transaction Overview Closing Announced sale of S&IP for $710 million to Owens & Minor, Inc. Includes Halyard brand name and current IT platform Use of Proceeds Net after-tax proceeds of approximately $600 million* Portion allocated to the corporate rebrand and new IT platform Rebranding expected in mid-2018 Ongoing evaluation of M&A opportunities Received regulatory approvals needed to close Expected to close at the end of Q TSAs Halyard will provide IT services to OMI for at least one year Finalizing TSAs and working to separate IT infrastructure Established governance process to manage transition Separation and close progressing as planned *Reflects recent tax legislation 4
6 Business drivers behind Halyard s future value creation 2017: Execution 2018: Separation 2019: Transformation : Acceleration End State 1 Growth Execution Organic Growth Driven by Innovation M&A to Accelerate Growth and Build Scale International Growth Breakthrough Products Accelerated Growth Right-Sized Organization 2 Organizational Optimization 3 Restructuring New Organizational Structure Transform IT Landscape / TSAs New Name & Brand Identity Enhanced Performance Through Commercial Excellence Elimination of Stranded Costs and Dis-synergies Supply Chain/Distribution Optimization Scalable Infrastructure Investment For Growth Margin Accretion 5
7 Positioned to win in core areas with attractive opportunities Strong Position in Large Addressable Market Pain Management Overview Chronic Care Overview Addressable Market Chronic Care Pain Management $6.0 B Medical Devices Sales Q Includes Surgical Pain and Interventional Pain Key therapies: - Non-opioid post surgical solutions - Radio frequency nerve ablation for chronic back, knee and hip pain Fastest-growing part of our business, driven by COOLIEF and ON-Q success Includes Digestive Health and Respiratory Health Key therapies: - Enteral and nasogastric feeding tubes - Closed suction catheters for infection control for ventilated patients Mature market, with leading positions further enhanced by success of CORPAK acquisition Pain Management Chronic Care 6
8 (%) Pain Management: Market development and broadening relevance Key Brands and Products Addressable Market: $4.5 B Interventional Pain Surgical Pain Historical Sales Growth E* T* Strategic Priorities Increasing reimbursement Enhancing innovation Growing clinical research Expanding site access and evolving call points Key Growth Drivers Battle against opioids Aging population Orthopedic expansion Mid-term technology innovation to support new procedures M&A focused on innovative treatments for pain * Target based on the midpoint of guidance 7
9 (%) Chronic Care: Exploring adjacencies and investing in commercial capabilities Key Brands and Products Addressable Market: $1.5 B Digestive Health Respiratory Health Strategic Priorities Pursuing complementary and transformational M&A Increasing product differentiation with technology Leveraging existing infrastructure Pursuing international growth as standard of care evolves Historical Sales Growth T* Key Growth Drivers Market growth and portfolio expansion International opportunities Alternate site expansion Commercial excellence Transformational M&A around minimally invasive treatments * Target based on the midpoint of guidance 8
10 Accelerating growth through R&D and innovation Investing in R&D Building strong R&D team through targeted device industry recruitment and M&A Increasing Product Launches in Devices Delivering disciplined project execution, realizing ROI on breakthrough products in Historic R&D investment up from 3% to 5%, targeting above 6% with greater focus on transformative R&D 3 (2015) 2 (2014) 5 (2016) 9 (2017) Go-forward Priorities Leveraging pain management center of excellence Increasing investment focused on transformative R&D Pursuing non-opioid pain therapies and technologies Looking into broader therapeutic applications Driving increased efficiency for healthcare practitioners Historical R&D Spending (% of Net Sales) LTM* * Q
11 Significant firepower for strategic M&A Strengthening capabilities following Corpak acquisition and S&IP divestiture Focus Strengthening M&A capability Completed strategic portfolio review Evaluating: - New and emerging technologies - Adjacent markets and additional platforms - Various transaction structures - Range of target sizes Criteria Leverages or expands call points, technologies or therapeutic solutions Develops our addressable market Ability to deliver growth and margins at or above current business Free cash flow generation Accretive over time Realizable synergy opportunities $700 - $750 million in M&A capacity following S&IP divestiture and change in tax legislation 10
12 Transformation to a right-sized, growing and scalable business Organic Top-line Growth: Halyard Today Flat Future Halyard Mid-single digit Gross Margin: Mid-30s Low-60s R&D*: 5% >6% SG&A* (ex. R&D) Post divestiture: Operating Margin Growth: *as % of sales Low-40s Flat Multi-year Growth Drivers Mid-30s Growing Organic growth and gross profit drop-through Cost take-outs ($30-$40 million in ) M&A opportunities 11
13 Focused Medical Devices company to deliver superior returns Pure-play Medical Devices company in attractive end markets Dual-track growth strategy focused on M&A and product development Scalable infrastructure and disciplined plan to right-size cost structure Invest in R&D capabilities and introduce innovative technology Allows for clear playbook for future double-digit revenue and earnings growth 12
14 APPENDICES 13
15 2017 outlook summary February August November Adjusted diluted EPS $1.70 to $2.00 $1.85 to $2.05 $2.03 to $2.13 Net sales 0% to 2% 0% to 2% 0% to 2% Medical Devices Includes 3% growth attributed to CORPAK 7% to 9% 7% to 9% 7% to 9% S&IP, excluding sales to Kimberly-Clark Contemplates 2% to 4% lower selling prices 0% to -2% 0% to -2% -1% to -3% S&IP sales to Kimberly-Clark $40M to $45M $40M to $45M $50M to $55M Corporate sales $10M to $15M $10M to $15M $10M to $15M FX translation impact on net sales 0% to -2% 0% to -2% 0% to -2% Commodity inflation $10M to $20M $5M to $10M $10M to $15M Research & Development $40M to $45M $40M to $45M $40M to $45M Adjusted effective tax rate 32% to 34% 32% to 34% 31% to 33% Note: Guidance updates denoted in bold text. 14
16 Non-GAAP reconciliations In millions Gross Profit Operating Profit Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, As reported $ $ $ $ $ 28.8 $ 20.9 $ 84.3 $ 71.6 Divestiture-related charges Spin-related transition charges 4.5 (1.6) (0.8) 10.6 Acquisition-related charges Litigation and legal Intangibles amortization As adjusted non-gaap $ $ $ $ $ 47.8 $ 42.7 $ $ Income before taxes Income tax provision Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended September 30, September 30, September 30, September 30, As reported $ 21.4 $ 12.7 $ 62.4 $ 47.4 $ (4.8) $ (3.6) $ (15.9) $ (17.6) Effective tax rate, as reported 22.4% 28.3% 25.5% 37.1% Divestiture-related charges (3.1) (3.1) Spin-related transition charges 6.7 (0.8) 10.6 (2.3) 0.2 (3.9) Acquisition-related charges (0.8) (1.7) (2.0) (5.6) Litigation and legal (1.3) (1.9) (6.5) (5.7) Intangibles amortization (2.0) (2.3) (6.0) (6.2) Regulatory tax changes 3.7 As adjusted non-gaap $ 40.4 $ 34.5 $ $ $ (12.0) $ (11.8) $ (33.3) $ (35.3) Effective tax rate, as adjusted 29.7% 34.2% 30.7% 33.8% 15
17 Non-GAAP reconciliations In millions, except per share amounts Net Income Three Months Ended Nine Months Ended September 30, September 30, As reported $ 16.6 $ 9.1 $ 46.5 $ 29.8 Diluted EPS, as reported $ 0.35 $ 0.19 $ 0.98 $ 0.63 Divestiture-related charges Spin-related transition charges 4.4 (0.6) 6.7 Acquisition-related charges Litigation and legal Intangibles amortization Thailand statutory tax rate change 3.7 As adjusted non-gaap $ 28.4 $ 22.7 $ 75.1 $ 69.0 Diluted EPS, as adjusted $ 0.60 $ 0.48 $ 1.58 $ 1.47 EBITDA Three Months Ended Nine Months Ended September 30, September 30, EBITDA, as reported $ 44.9 $ 37.5 $ $ Divestiture-related charges Spin-related transition charges 6.7 (0.8) 10.6 Acquisition-related charges Litigation and legal Adjusted EBITDA $ 58.5 $ 53.3 $ $
18 Non-GAAP reconciliations In millions Medical Devices: Three Months Ended Nine Months Ended Twelve Months Ended ($ in millions) December 31, 2016 September 30, 2017 September 30, 2017 Net Sales $ $ $ Operating Profit Operating Profit Margin 21.6 % 26.1 % 24.9 % Free Cash Flow Three Months Ended Nine Months Ended September 30, September 30, Cash provided by operating activities $ 23.4 $ 49.9 $ 80.1 $ Capital expenditures (14.0) (7.6) (30.6) (21.7) Free Cash Flow $ 9.4 $ 42.3 $ 49.5 $
19 Non-GAAP reconciliations In millions, except per share amounts Estimated Range Adjusted diluted earnings per share $ 2.03 to $ 2.13 Amortization (0.28) to (0.28) Divestiture-related charges (0.33) to (0.26) Spin-related transition expenses 0.01 to 0.01 Acquisition related charges (0.09) to (0.07) Other (0.38) to (0.28) Diluted earnings per share (GAAP) $ 0.96 to $
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook and Update on Divestiture 2018 Priorities Steve Voskuil Chief Financial Officer
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO
J.P. MORGAN HEALTHCARE CONFERENCE Robert Abernathy Chairman and CEO OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and conference call, including our 2016 outlook, expectations
More informationFIRST QUARTER 2018 EARNINGS CALL MAY 2, 2018
FIRST QUARTER 2018 EARNINGS CALL MAY 2, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook Update on 2018 Priorities Steve Voskuil Chief Financial Officer First Quarter Financial
More informationSECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017
SECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017 SECOND QUARTER EARNINGS CALL AGENDA CEO Transition Robert Abernathy Chairman Strategic Vision Joe Woody Chief Executive Officer Second Quarter Results and
More informationSECOND QUARTER 2018 EARNINGS CALL. August 7, 2018
SECOND QUARTER 2018 EARNINGS CALL August 7, 2018 1 AGENDA AND SPEAKERS Joe Woody Chief Executive Officer V NOS Outlook Update on 2018 Priorities Steve Voskuil Chief Financial Officer Second Quarter Financial
More informationFOURTH QUARTER 2015 EARNINGS CALL. February 29, 2016
FOURTH QUARTER 2015 EARNINGS CALL February 29, 2016 FOURTH QUARTER EARNINGS CALL AGENDA Fourth Quarter Update Robert Abernathy, Chairman and Chief Executive Officer Fourth Quarter Results and 2016 Outlook
More informationSECOND QUARTER 2016 EARNINGS CALL. August 3, 2016
SECOND QUARTER 2016 EARNINGS CALL August 3, 2016 SECOND QUARTER EARNINGS CALL AGENDA Second Quarter Update Robert Abernathy, Chairman and Chief Executive Officer Second Quarter Results and 2016 Outlook
More informationTHIRD QUARTER 2018 EARNINGS CALL. November 6, 2018
THIRD QUARTER 2018 EARNINGS CALL November 6, 2018 1 AGENDA AND SPEAKERS Joe Woody Chief Executive Officer Progress on 2018 Priorities V NOS Outlook Steve Voskuil Chief Financial Officer Third Quarter Financial
More informationFourth Quarter 2014 Earnings Call. March 4, 2015
March 4, 2015 Conference Call Reminders Forward-Looking Information Certain matters in this presentation and conference call, including our 2015 outlook, expectations and planning assumptions, and any
More informationFirst Quarter 2018 Financial Results. January 26, 2018
First Quarter 2018 Financial Results January 26, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationThird Quarter 2018 Financial Results. July 27, 2018
Third Quarter 2018 Financial Results July 27, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationSecond Quarter 2018 Financial Results. April 27, 2018
Second Quarter 2018 Financial Results April 27, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationMorgan Stanley 5 th Annual Laguna Conference
September 14, 2017 Morgan Stanley 5 th Annual Laguna Conference Bob Livingston President & Chief Executive Officer Forward Looking Statements This presentation may contain "forward-looking" statements
More informationThird Quarter Earnings November 8, 2018
Third Quarter Earnings November 8, 2018 Forward Looking Statements & Disclosures Forward Looking Statement: With the exception of the historical information contained in this presentation, the matters
More informationNovember 1, Q Earnings Presentation
November 1, 2018 Q3 2018 Earnings Presentation Certain statements contained in this presentation that are not historical facts, including any statements as to future market conditions, results of operations,
More informationJP Morgan Healthcare Conference January 13, 2016
JP Morgan Healthcare Conference January 13, 2016 FORWARD-LOOKING STATEMENTS Certain statements and information in this presentation may be deemed to be forward-looking statements within the meaning of
More informationCompelling Strategic Transaction
ACQUISITION OF DJO GLOBAL November 19, 2018 Forward Looking Statements & Non-GAAP Disclaimer The following information may contain forward-looking statements, including forward-looking statements within
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Healthcare Conference, September 2017 NASDAQ: NOVT 1 Safe Harbor Statement The statements in this presentation
More informationinvestmnt Conference August 5, 2015 Susie Lisa, CFA Vice President, Investor Relations
investmnt Conference August 5, 2015 Susie Lisa, CFA Vice President, Investor Relations 1 Safe harbor for forward-looking statements and Disclaimers This presentation contains forward-looking statements
More informationSTRYKER. Kevin A. Lobo, President & Chief Executive Officer
STRYKER Kevin A. Lobo, President & Chief Executive Officer January 15, 2014 FORWARD LOOKING STATEMENT Certain statements made in the presentation may contain information that includes or is based on forward-looking
More informationCorporate Presentation. November 2018
Corporate Presentation November 2018 1 Safe Harbor / Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time to time make, "forward-looking statements"
More informationJ.P. MORGAN HEALTHCARE CONFERENCE January 10, 2017
J.P. MORGAN HEALTHCARE CONFERENCE January 10, 2017 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference John J. Greisch, President and CEO January 9, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform
More informationINVESTOR UPDATE NOVEMBER 2017
INVESTOR UPDATE NOVEMBER 2017 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL INFORMATION Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking
More informationInvestor Presentation
Leading the World in Essentials for a Better Life Investor Presentation Financial Information as of December 31, 2014 www.kimberly-clark.com Highlights $20 billion global company founded in 1872 Products
More informationOwens & Minor Reports 3rd Quarter 2017 Financial Results
November 1, 2017 Owens & Minor Reports 3rd Quarter 2017 Financial Results Owens & Minor to acquire the Surgical & Infection Prevention Business of Halyard Health in a $710 million transaction RICHMOND,
More informationCardinal Health Annual Meeting of Shareholders. George S. Barrett Chairman and Chief Executive Officer November 8, 2017
Cardinal Health Annual Meeting of Shareholders George S. Barrett Chairman and Chief Executive Officer November 8, 2017 Forward-looking statements and GAAP reconciliation This presentation contains forward-looking
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Industrial Conference, November 2017 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement
More informationGardner Denver Q Earnings Presentation. April 27, 2018
Gardner Denver Q1 2018 Earnings Presentation April 27, 2018 Replay Information Dial toll-free: +1.877.344.7529 International: +1.412.317.0088 Conference ID: #10119481 Log on to: http://investors.gardnerdenver.com
More informationCardinal Health 36 th Annual JP Morgan Healthcare Conference
Cardinal Health 36 th Annual JP Morgan Healthcare Conference Mike Kaufmann Chief Executive Officer Monday, January 8, 2018 Copyright 2018, Cardinal Health, Inc. or one of its subsidiaries. All rights reserved
More informationMYERS INDUSTRIES, INC. Third Quarter 2018 Earnings Presentation
MYERS INDUSTRIES, INC. Third Quarter 2018 Earnings Presentation SAFE HARBOR STATEMENT & NON-GAAP MEASURES Statements in this presentation include forward-looking statements within the meaning of the Private
More informationPERFORMANCE AND TRAJECTORY
PERFORMANCE AND TRAJECTORY José (Joe) E. Almeida Chairman, President and CEO May 21, 2018 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results,
More informationEnergizer Investor Call. November 15, 2018
Energizer Investor Call November 15, 2018 Cautionary Note Regarding Forward- Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation
More informationHorizon Global First Quarter 2016 Earnings Presentation
Horizon Global First Quarter 2016 Earnings Presentation May 3, 2016 1 Safe Harbor Statement Forward-Looking Statements This presentation may contain "forward-looking statements" as defined in the Private
More informationFirst-Quarter 2018 Earnings
First-Quarter 208 Earnings Baxter International Inc. April 26, 208 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results, business development
More informationQ Financial Supplement
Reconcilation of GAAP and Non-GAAP Financial Measures Non-GAAP Net Income and Non-GAAP EPS (in thousands except per share data) 2014 2015 Three Months Ending June 30, Low Range Guidance (1) High Range
More informationMSCI. J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO. February 28, 2017
MSCI J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO February 28, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document.
More informationMylan Q EARNINGS November 5, Q Earnings All Results are Unaudited
Mylan Q3 EARNINGS November 5, Q3 Earnings All Results are Unaudited Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to the safe harbor
More informationEarnings Presentation October 25, 2018
nvent Third Quarter 2018 Earnings Presentation October 25, 2018 Forward-Looking Statement CAUTION CONCERNING FORWARD-LOOKING STATEMENTS This presentation contains statements that we believe to be "forward-looking
More informationRaymond James 37 th Annual Institutional Investors Conference. March 8, 2016
Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,
More informationIntegra Investor Presentation November 13, 2014 San Francisco, CA. Investor Meeting at the North American Spine Society
Integra Investor Presentation November 13, 2014 San Francisco, CA Investor Meeting at the North American Spine Society 1 Forward-Looking Statements Safe Harbor and Non-GAAP Financial Measures Certain statements
More information2018 Financial Outlook
2018 Financial Outlook Nick Gangestad Senior Vice President and Chief Financial Officer December 12, 2017 1 Agenda Executing on our 2016 2020 plan Tracking to the top-half of 2017 full-year organic growth
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Alistair Macdonald Chief Executive Officer January 8, 2019 Forward-Looking Statements, Non-GAAP Financial Measures, and Basis of Financial Presentation Forward-Looking
More informationUBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017
UBS Healthcare Conference John J. Greisch, President and CEO May 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, within the meaning of the Private Securities
More informationHill-Rom Highlights Long-Term Strategic And Financial Objectives
NEWS RELEASE Hill-Rom Highlights Long-Term Strategic And Financial Objectives 11/3/2017 2020 Outlook Reflects Value of Diversification and Innovation, Portfolio and Business Optimization Initiatives, and
More informationGCP Applied Technologies. Strategy Update August 3, 2017
GCP Applied Technologies Strategy Update August 3, 2017 Forward Looking Statements This document contains, and our other public communications may contain, forward-looking statements, that is, information
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationQ Earnings Call February 20, 2019
Q4 2018 Earnings Call February 20, 2019 1 Forward-looking statements Safe Harbor Statement This release contains forward-looking statements, which may concern our plans, objectives, outlook, goals, strategies,
More informationAcquisition of Dealer Inspire and Launch Digital Marketing
Acquisition of Dealer Inspire and Launch Digital Marketing Investor Presentation February 14, 2018 Forward Looking Statements This presentation contains forward looking statements within the meaning of
More informationFebruary 14, Q Earnings Presentation
February 14, 2019 Q4 2018 Earnings Presentation Certain statements contained in this presentation that are not historical facts, including any statements as to future market conditions, results of operations,
More informationBaird 2018 Global Healthcare Conference. September 5, 2018
Baird 2018 Global Healthcare Conference September 5, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationDANAHER CORPORATION Second Quarter 2018 Earnings Release. July 19, 2018
DANAHER CORPORATION Second Quarter 2018 Earnings Release July 19, 2018 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding the
More informationCowen and Company 38 th Annual Health Care Conference. March 13, 2018
Cowen and Company 38 th Annual Health Care Conference March 13, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking
More informationNuVasive, Inc. 34 th Annual J.P. Morgan Healthcare Conference
NuVasive, Inc. 34 th Annual J.P. Morgan Healthcare Conference January 12, 2016 Greg Lucier Chairman and Chief Executive Officer Safe Harbor Statements Forward-looking information and non-gaap measures
More information3D Systems Reports Fourth Quarter and Full Year 2017 Financial Results
3D Systems Corporation 333 Three D Systems Circle Rock Hill, SC 29730 News Release www.3dsystems.com NYSE: DDD Investor Contact: Stacey Witten Email: investor.relations@3dsystems.com Media Contact: Greg
More informationMylan: Q EARNINGS August 8, Q Earnings All Results are Unaudited
Mylan: Q2 2018 EARNINGS August 8, 2018 Q2 2018 Earnings All Results are Unaudited Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to
More informationStryker. Kevin A. Lobo Chairman and Chief Executive Officer
Stryker Kevin A. Lobo Chairman and Chief Executive Officer Disclaimer Forward-looking statement This presentation contains information that includes or is based on forward looking statements within the
More informationAWI to Sell EMEA and Pacific Rim Businesses
Exhibit 99.1 November 21, 2017 AWI to Sell EMEA and Pacific Rim Businesses Safe Harbor Statement 2 Our disclosures in this presentation, including without limitation, those relating to future financial
More informationQ EARNINGS Presentation
Q2 2018 EARNINGS Presentation Disclosures This presentation contains non-gaap financial measures relating to our performance. You can find the reconciliation of these measures to the most directly comparable
More informationQ Earnings. November 1, 2017
Q4 2017 Earnings November 1, 2017 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S.
More informationGardner Denver Reports Strong Second Quarter 2018 Results and Raises Full Year 2018 Adjusted EBITDA Midpoint Guidance
August 1, 2018 Gardner Denver Reports Strong Second Quarter 2018 Results and Raises Full Year 2018 Adjusted EBITDA Midpoint Guidance Revenues of $668.2 million increased 15% over the prior year, supported
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers February 2018 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement The statements in this
More informationFINANCIAL OVERVIEW AL MISTYSYN SENIOR VICE PRESIDENT, FINANCE & CHIEF FINANCIAL OFFICER FINANCIAL COMMUNITY PRESENTATION OCTOBER 3, 2017
FINANCIAL OVERVIEW AL MISTYSYN SENIOR VICE PRESIDENT, FINANCE & CHIEF FINANCIAL OFFICER FINANCIAL COMMUNITY PRESENTATION OCTOBER 3, 2017 Forward Looking Statement The presentations today will contain certain
More informationSurgical Care Affiliates, Inc. 32 nd Annual J.P. Morgan Healthcare Conference. January 2014
Surgical Care Affiliates, Inc. 32 nd Annual J.P. Morgan Healthcare Conference January 2014 Disclaimer Certain statements herein are forward-looking statements made pursuant to the safe harbor provisions
More informationBottomline Technologies Reconciliation to Non GAAP Measures Three Months Ended June 30, 2013
Reconciliation to Measures Three Months Ended June 30, 2013 Non Cash Amortization of Equity Based Integration Restructuring Interest GAAP Intangible Assets Compensation Related Expenses Expenses Expense
More informationJ.P. Morgan Diversified Industrials Conference. Dave Anderson Senior Vice President and CFO
J.P. Morgan Diversified Industrials Conference 0 Dave Anderson Senior Vice President and CFO Forward Looking Statements This report contains forward-looking statements within the meaning of Section 21E
More informationAvery Dennison Jefferies Industrials Conference
Avery Dennison Jefferies Industrials Conference August 9, 2016 Anne Bramman SVP and Chief Financial Officer 1 Avery Dennison Investor Presentation Forward-Looking Statements Certain statements contained
More informationAcquisition of Astra Tech June 22, 2011 NASDAQ-XRAY
Acquisition of Astra Tech June 22, 2011 1 Forward Looking Statements This presentation, in addition to historical information, contains forward-looking statements (as defined in the Securities Litigation
More information36 th Annual J.P. Morgan Healthcare Conference. January 10, 2018
36 th Annual J.P. Morgan Healthcare Conference January 10, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationCardinal Health 39 th Annual Raymond James Institutional Investors Conference Mike Kaufmann Chief Executive Officer
Cardinal Health 39 th Annual Raymond James Institutional Investors Conference Mike Kaufmann Chief Executive Officer Tuesday, March 6, 2018 Copyright 2018, Cardinal Health, Inc. or one of its subsidiaries.
More informationThird Quarter 2018 Teleconference Supplemental Data
Third Quarter 2018 Teleconference Supplemental Data Cautionary Statement Forward-Looking Information This communication contains forward looking statements as that term is defined in the Private Securities
More informationInvestor Presentation. August 2007
Investor Presentation August 2007 Forward-Looking Statement This presentation should be considered forward-looking and is subject to various risk factors and uncertainties. For more information on those
More informationQ Earnings. January 24, 2018
Q1 2018 Earnings January 24, 2018 Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains certain forward-looking statements within the meaning of the U.S.
More information2Q18 Earnings Conference Call. August 2, 2018
2Q18 Earnings Conference Call August 2, 2018 Presentation of Financial Information & Forward-Looking Statements Historical financial and operating data in this presentation reflect the consolidated results
More informationAnalog Devices Reports Second Quarter Fiscal Year 2014 Results
May 20, Analog Devices Reports Second Quarter Fiscal Year Results Board declares $0.37 per share cash dividend NORWOOD, Mass.--(BUSINESS WIRE)-- Analog Devices, Inc. (NASDAQ: ADI), a global leader in high-performance
More informationWilliam Blair 35 th Annual Growth Stock Conference. June 9, 2015 NYSE: Q. Copyright 2014 Quintiles
William Blair 35 th Annual Growth Stock Conference June 9, 2015 Copyright 2014 Quintiles NYSE: Q Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking
More informationGardner Denver Third Quarter 2017 Earnings Presentation. October 26, 2017
Gardner Denver Third Quarter 2017 Earnings Presentation October 26, 2017 Replay Information Dial toll-free: +1.877.344.7529 International: +1.412.317.0088 Conference ID: #10113255 Log on to: http://investors.gardnerdenver.com
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION HURN I Q3 2016 2016 HURON CONSULTING GROUP INC. FORWARD-LOOKING STATEMENTS Statements in this press release that are not historical in nature, including those concerning the Company
More informationEnergizer to Acquire Spectrum Brands Global Battery and Portable Lighting Business. January 16, 2018
Energizer to Acquire Spectrum Brands Global Battery and Portable Lighting Business January 16, 2018 Safe Harbor Statement Unless the context otherwise requires, references in this presentation to Energizer,
More informationQ4 FY18 CARDINAL HEALTH, INC. EARNINGS CALL AUGUST 6, 2018
Q4 FY18 CARDINAL HEALTH, INC. EARNINGS CALL AUGUST 6, 2018 1 Forward-looking statements and GAAP reconciliation Cautions Concerning Forward-Looking Statements This presentation contains forward-looking
More informationMcKesson Corporation J.P. Morgan Healthcare Conference
McKesson Corporation J.P. Morgan Healthcare Conference John Hammergren Chairman and Chief Executive Officer Forward-Looking Statements Some of the information in this presentation is not historical in
More informationWILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL
WILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL FORWARD LOOKING STATEMENT AND USE OF ADJUSTED MEASURES This presentation contains forward-looking statements including but not limited to
More informationCautionary Statement Regarding Forward-Looking Information
Ecolab 1 Fourth Quarter 2011 Teleconference Supplemental Data Cautionary Statement Cautionary Statement Regarding Forward-Looking Information This communication contains various "Forward-Looking Statements"
More informationCRANE CO. FINANCIAL OVERVIEW
CRANE CO. FINANCIAL OVERVIEW RICHARD MAUE CHIEF FINANCIAL OFFICER 1 Financial Overview 2016 Results 2017 Outlook Free Cash Flow and Capital Deployment Long Term Outlook 2 2016 Operating Results ($ Millions,
More informationMagellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017
Magellan Health Cantor Fitzgerald Healthcare Conference September 26, 2017 Cautionary Statement and Non-GAAP measures 2 This slide presentation and our accompanying oral comments include forward-looking
More informationEndo International plc
Endo International plc Q1 2015 Earnings Report May 11, 2015 Forward Looking Statements; Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private
More informationHorizon Global Third Quarter 2017 Earnings Presentation
Horizon Global Third Quarter 2017 Earnings Presentation October 31, 2017 Q1 2016 Earnings 1 Safe Harbor Statement Forward-Looking Statements This presentation may contain "forward-looking statements" as
More informationFourth Quarter Fiscal Year 2017
Fourth Quarter Fiscal Year 2017 October 25, 2017 J. Michael Bruff Vice President Investor Relations Mike.Bruff@Varian.com This presentation is intended exclusively for investors. It is not intended for
More information2017 WELLS FARGO HEALTHCARE CONFERENCE
2017 WELLS FARGO HEALTHCARE CONFERENCE September 7, 2017 TRANSFORMING HEALTHCARE TOGETHER UNIQUELY POSITIONED FOR THE FUTURE 2017 1 Craig McKasson Chief Financial Officer Premier Inc. TRANSFORMING HEALTHCARE
More informationCombination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014
Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014 David Dvorak President and Chief Executive Officer Jim Crines EVP, Finance, and Chief Financial Officer Cautionary Statement
More informationThird-Quarter Fiscal 2018 Financial Results & Update
Third-Quarter Fiscal 2018 Financial Results & Update May 7, 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures Forward-looking Statements
More informationXylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016
1 Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016 Forward-Looking Statements This presentation contains information that may constitute forward-looking statements.
More informationForward Looking Statements
Forward Looking Statements This presentation, as well as other statements made by Aptiv PLC (the Company ), contain forward-looking statements that reflect, when made, the Company s current views with
More informationECOLAB THIRD QUARTER 2018
3Q 2018 Overview Sales: ECOLAB THIRD QUARTER 2018 Reported sales +5%; fixed currency sales were +6%, with acquisition adjusted fixed currency sales +7%. New business growth, share gains, pricing and new
More informationSECOND QUARTER 2018 BUSINESS REVIEW. Jonathan W. Painter, President & CEO Michael J. McKenney, Executive Vice President & CFO
SECOND QUARTER 2018 BUSINESS REVIEW Jonathan W. Painter, President & CEO Michael J. McKenney, Executive Vice President & CFO Forward-Looking Statements The following constitutes a Safe Harbor statement
More informationAllscripts Healthcare Solutions
Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationQuad/Graphics Reports Second Quarter and Year-to-Date 2017 Results
FOR IMMEDIATE RELEASE Quad/Graphics Reports Second Quarter and Year-to-Date 2017 Results Consistent Execution of Strategic Objectives Drives Increased Net Earnings and Margins SUSSEX, WI, August 1, 2017
More informationDANAHER CORPORATION Tom Joyce, President & CEO J.P. MORGAN HEALTHCARE CONFERENCE JANUARY 8, 2019
DANAHER CORPORATION Tom Joyce, President & CEO J.P. MORGAN HEALTHCARE CONFERENCE JANUARY 8, 2019 Forward Looking Statements Statements in this presentation that are not strictly historical, including any
More informationPAREXEL INTERNATIONAL
PAREXEL INTERNATIONAL Jefferies Healthcare Conference June 8, 2016 2015 PAREXEL INTERNATIONAL CORP. SAFE HARBOR This presentation contains forward-looking statements within the meaning of Section 27A of
More information